StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3085% below fair value
$0.82−0.06 (-7.10%)

Close on Nov 20, 2026Market cap $9.68MP/E –Yield –

Bionano Genomics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Bionano Genomics's free cash flow for the twelve months ending Sep 30, 2021 was -$58.75M. For fiscal 2020 it was -$38.31M.

Annual free cash flow

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$38.31M–
FY2019Dec 31, 2019-$29.59M–
FY2018Dec 31, 2018-$20.28M–
FY2017Dec 31, 2017-$21.84M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2021Sep 30, 2021-$20.25M–
Q2 FY2021Jun 30, 2021-$12.47M–
Q1 FY2021Mar 31, 2021-$13.93M–
Q4 FY2020Dec 31, 2020-$12.10M–
Q3 FY2020Sep 30, 2020-$10.96M–
Q2 FY2020Jun 30, 2020-$7.22M–
Q1 FY2020Mar 31, 2020-$8.03M–
Q4 FY2019Dec 31, 2019-$9.40M–
Q3 FY2019Sep 30, 2019-$7.29M–
Q2 FY2019Jun 30, 2019-$6.35M–
Q1 FY2019Mar 31, 2019-$6.55M–
Q4 FY2018Dec 31, 2018-$4.10M–
Q3 FY2018Sep 30, 2018-$6.23M–
Q2 FY2018Jun 30, 2018-$3.14M–
Q1 FY2018Mar 31, 2018-$6.80M–
Q4 FY2017Dec 31, 2017-$3.09M–

More Bionano Genomics figures

See a number that looks wrong?